Homburger advised Siegfried Holding AG in connection with the bridge financing for the acquisition of three drug substances sites in the US and Australia

On May 1, 2026, Siegfried Holding AG, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, closed the acquisition of three drug substances sites in the US and Australia from an affiliate of SK Capital Partners.

Homburger acted as counsel to Siegfried Holding AG in connection with a Swiss law-governed bridge term facility agreement with UBS Switzerland AG as mandated lead arranger and lender.

The Homburger team was led by Jürg Frick (Financing) and included Stefan Bindschedler (Financing) as well as Stefan Oesterhelt (Tax).